substance p has been researched along with ezlopitant in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Russell, IJ | 1 |
| Kamel, AM; Massefski, WW; Zandi, KS | 1 |
| Eggan, BL; McCallum, SE | 1 |
1 review(s) available for substance p and ezlopitant
| Article | Year |
|---|---|
The promise of substance P inhibitors in fibromyalgia.
Topics: Benzene Derivatives; Fibromyalgia; Humans; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Substance P | 2002 |
2 other study(ies) available for substance p and ezlopitant
| Article | Year |
|---|---|
Identification of the degradation product of ezlopitant, a non-peptidic substance P antagonist receptor, by hydrogen deuterium exchange, electrospray ionization tandem mass spectrometry (ESI/MS/MS) and nuclear magnetic resonance (NMR) spectroscopy.
Topics: Benzylamines; Bridged Bicyclo Compounds, Heterocyclic; Deuterium; Magnetic Resonance Spectroscopy; Protons; Spectrometry, Mass, Electrospray Ionization; Substance P | 2003 |
α3β4 nicotinic receptors in the medial habenula and substance P transmission in the interpeduncular nucleus modulate nicotine sensitization.
Topics: Analysis of Variance; Animals; Benzylamines; Bridged Bicyclo Compounds, Heterocyclic; Cholinergic Antagonists; Chromatography, High Pressure Liquid; Dihydro-beta-Erythroidine; Dopamine; Dose-Response Relationship, Drug; Female; Interpeduncular Nucleus; Microdialysis; Nicotine; Nicotinic Agonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Signal Transduction; Substance P | 2017 |